Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

15-Year watch begins for transplant patients given 'Smart' immune cells

NCT ID NCT05987527

First seen Jan 05, 2026 · Last updated May 23, 2026 · Updated 22 times

Summary

This study follows 11 kidney transplant patients who received a special cell therapy (CAR-Treg) designed to prevent organ rejection. Researchers will track their health and kidney function for up to 15 years to see if the therapy remains safe and helps protect the transplanted kidney. The goal is to understand long-term risks and benefits, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Erasmus MC, University Medical Center

    Rotterdam, Netherlands

  • Leiden University Medical Centre

    Leiden, Netherlands

  • Oxford University Hospitals NHS Foundation Trust

    Oxford, United Kingdom

  • University Hospitals Leuven

    Leuven, Belgium

  • University Medical Center Groningen

    Groningen, Netherlands

Conditions

Explore the condition pages connected to this study.